U
Urologix, Inc. ULGX
$0.0001 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--
ULGX market cap represents 0.00% of the industry.
Valuation
ULGX
Low
ULGX
Industry Average
High
Market Cap
2.13K
< 2.12K
> 20.77B
Enterprise Value
--
-303.52M
546.68B
Price/Earnings (TTM)
--
-218.42
1,526.65
Earnings Per Share Growth (TTM)
--
-4,455.45%
19,629.41%
Price/Earnings To Growth (TTM)
--
0.01
9.63
Price/Sales (TTM)
--
-0.633
589.474
Price/Book (Q)
--
-104.07
238.18
Enterprise Value/Revenue (TTM)
--
-19.37
535.77
Enterprise Value/EBITDA (TTM)
--
-5,443.64
219.57
Enterprise Value/EBIT (TTM)
--
-1,425.77
300.42
Dividends and Shares
ULGX
Low
ULGX
Industry Average
High
Shares Outstanding
--
105.80K
1.75B
Dividend Per Share (Most Recent)
--
0.03
2.10
Dividend Per Share (TTM)
--
0.03
8.40
Dividend Yield (TTM)
--
0.19%
7.75%
Payout Ratio (TTM)
--
-1,820.24
926.87
Price History
ULGX
Low
ULGX
Industry Average
High
Beta
-148.97
-42.88
3.76
1-Month Total Return
9,900.00%
< -20.00%
797.52%
3-Month Total Return
0.00%
< -30.00%
> 0.00%
6-Month Total Return
9,900.00%
< 0.00%
604.55%
Year to Date Total Return
0.00%
< -20.00%
> 0.00%
1-Year Total Return
0.00%
< 0.00%
> 10.00%
2-Year Total Return
0.00%
< 0.00%
> 30.00%
3-Year Total Return
0.00%
< -40.00%
> 0.00%
5-Year Total Return
-97.50%
-100.00%
> 340.00%
Profitability
ULGX
Low
ULGX
Industry Average
High
Operating Margin (TTM)
--
-100,570.96%
423.48%
Profit Margin (TTM)
--
-73,864.51%
480.40%
Management Effectiveness
ULGX
Low
ULGX
Industry Average
High
Return on Assets (TTM)
--
-272.95%
23.87%
Return on Equity (TTM)
--
0.36%
824.40%
Income Statement
ULGX
Low
ULGX
Industry Average
High
Revenue (TTM)
--
-4.27M
370.66B
Total Revenue (TTM)
--
-4.27M
400.28B
Total Revenue Growth (Q YOY)
--
-98.51%
137,800.00%
Revenue Per Share (TTM)
--
-8.53
2,721.82
Gross Profit (TTM)
--
-6.05M
89.40B
EBITDA (TTM)
--
-401.33M
36.39B
EBIT (TTM)
--
-443.71M
32.29B
Net Income (TTM)
--
-2.05B
14.41B
Net Income Avl. to Common (TTM)
--
-2.05B
14.41B
Earnings Growth (Q YOY)
--
-23,034.35%
1,990.36%
EPS Diluted (TTM)
--
-101.97
32.22
EPS Diluted Growth (Q YOY)
--
-24,641.75%
39,800.00%
Balance Sheet
ULGX
Low
ULGX
Industry Average
High
Cash and Short-Term Inv. (Q)
--
45.00K
34.68B
Cash Per Share (Q)
--
0.01
727.01
Total Current Assets (Q)
--
18.60K
85.78B
Total Assets (Q)
--
941.70K
298.28B
Total Current Liabilities (Q)
--
110.30K
103.77B
Total Debt (Q)
--
0.00
82.92B
Total Liabilities (Q)
--
272.00K
195.69B
Total Common Equity (Q)
--
-3.08B
92.66B
Total Preferred Equity (Q)
--
0.00
920.42M
Total Equity (Q)
--
-2.92B
102.59B
Current Ratio (Q)
--
0.111
25.640
Book Value Per Share (Q)
--
-2,390.68
181.62
Cash Flow
ULGX
Low
ULGX
Industry Average
High
Cash from Operations (TTM)
--
-804.60M
24.20B
Cash from Investing (TTM)
--
-20.53B
3.43B
Cash from Financing (TTM)
--
-7.65B
1.96B
Net Change in Cash (TTM)
--
-3.30B
1.91B
Levered Free Cash Flow (TTM)
--
-1.42B
12.15B
TTM - Trailing twelve months. Q - Most recent quarter. YOY - Year over year.
The comparison requires a security to have a minimum 30 day average trading volume of 100,000 at $1 or over, or a $5 minimum price.
* Lowest and highest value for any one individual security in the industry.
Weiss Ratings